Cover
Cover | Oct. 13, 2021 |
Cover [Abstract] | |
Document Type | 8-K/A |
Amendment Flag | true |
Amendment Description | This Current Report on Form 8-K/A is being filed as an amendment to the Current Report on Form 8-K filed by InMed Pharmaceuticals Inc. (“InMed” or the “Company”) with the Securities and Exchange Commission (“SEC”) on October 13, 2021. |
Document Period End Date | Oct. 13, 2021 |
Entity File Number | 001-39685 |
Entity Registrant Name | INMED PHARMACEUTICALS INC. |
Entity Central Index Key | 0001728328 |
Entity Tax Identification Number | 98-1428279 |
Entity Incorporation, State or Country Code | A1 |
Entity Address, Address Line One | Suite 310 - 815 W. Hastings Street |
Entity Address, City or Town | Vancouver, B.C. |
Entity Address, Country | CA |
Entity Address, Postal Zip Code | V6C 1B4 |
City Area Code | (604) |
Local Phone Number | 669-7207 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Shares, no par value |
Trading Symbol | INM |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | false |